Annual CFI:
-$262.72M-$165.81M(-171.10%)Summary
- As of today, HALO annual cash from investing is -$262.72 million, with the most recent change of -$165.81 million (-171.10%) on December 31, 2024.
- During the last 3 years, HALO annual cash from investing has risen by +$143.57 million (+35.34%).
- HALO annual cash from investing is now -435.30% below its all-time high of $78.35 million, reached on December 31, 2020.
Performance
HALO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
$84.79M+$175.21M(+193.77%)Summary
- As of today, HALO quarterly cash from investing is $84.79 million, with the most recent change of +$175.21 million (+193.77%) on June 30, 2025.
- Over the past year, HALO quarterly cash from investing has increased by +$126.83 million (+301.69%).
- HALO quarterly cash from investing is now at all-time high.
Performance
HALO Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$143.64M+$126.83M(+46.89%)Summary
- As of today, HALO TTM cash from investing is -$143.64 million, with the most recent change of +$126.83 million (+46.89%) on June 30, 2025.
- Over the past year, HALO TTM cash from investing has increased by +$72.82 million (+33.64%).
- HALO TTM cash from investing is now -212.15% below its all-time high of $128.08 million, reached on September 30, 2019.
Performance
HALO TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
HALO Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | -171.1% | +301.7% | +33.6% |
3Y3 Years | +35.3% | +119.5% | +82.1% |
5Y5 Years | -4634.6% | +612.6% | -39.6% |
HALO Cash From Investing Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | -171.1% | +46.0% | at high | +150.6% | -1713.1% | +81.7% |
5Y | 5-Year | -435.3% | +46.0% | at high | +119.5% | -283.3% | +82.1% |
All-Time | All-Time | -435.3% | +46.0% | at high | +119.5% | -212.2% | +82.1% |
HALO Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $84.79M(+193.8%) | -$143.64M(+46.9%) |
Mar 2025 | - | -$90.42M(-406.7%) | -$270.46M(-2.9%) |
Dec 2024 | -$262.72M(-171.1%) | $29.48M(+117.6%) | -$262.72M(+12.6%) |
Sep 2024 | - | -$167.48M(-298.4%) | -$300.49M(-38.8%) |
Jun 2024 | - | -$42.04M(+49.2%) | -$216.46M(-81.2%) |
Mar 2024 | - | -$82.68M(-897.2%) | -$119.43M(-23.2%) |
Dec 2023 | -$96.91M(+80.1%) | -$8.29M(+90.1%) | -$96.91M(-7.2%) |
Sep 2023 | - | -$83.45M(-251.7%) | -$90.36M(-1040.7%) |
Jun 2023 | - | $54.99M(+191.4%) | -$7.92M(+98.4%) |
Mar 2023 | - | -$60.16M(-3345.7%) | -$497.86M(-2.2%) |
Dec 2022 | -$487.00M(-19.9%) | -$1.75M(-73.2%) | -$487.00M(+37.9%) |
Sep 2022 | - | -$1.01M(+99.8%) | -$784.73M(+2.0%) |
Jun 2022 | - | -$434.95M(-782.2%) | -$800.67M(-95.1%) |
Mar 2022 | - | -$49.30M(+83.5%) | -$410.34M(-1.0%) |
Dec 2021 | -$406.29M(-618.5%) | -$299.47M(-1666.4%) | -$406.29M(-739.8%) |
Sep 2021 | - | -$16.95M(+62.0%) | -$48.38M(+21.4%) |
Jun 2021 | - | -$44.62M(+1.4%) | -$61.52M(-1129.2%) |
Mar 2021 | - | -$45.25M(-177.4%) | -$5.00M(-106.4%) |
Dec 2020 | $78.35M(+1512.0%) | $58.44M(+294.2%) | $78.35M(+176.1%) |
Sep 2020 | - | -$30.09M(-352.9%) | -$102.91M(-223.5%) |
Jun 2020 | - | $11.90M(-68.8%) | -$31.81M(-949.0%) |
Mar 2020 | - | $38.11M(+131.0%) | $3.75M(+167.5%) |
Dec 2019 | -$5.55M(-322.6%) | -$122.82M(-399.6%) | -$5.55M(-104.3%) |
Sep 2019 | - | $41.00M(-13.6%) | $128.08M(+4.8%) |
Jun 2019 | - | $47.46M(+64.7%) | $122.27M(+81.9%) |
Mar 2019 | - | $28.81M(+166.6%) | $67.21M(+2595.8%) |
Dec 2018 | $2.49M(+101.5%) | $10.81M(-69.3%) | $2.49M(+101.6%) |
Sep 2018 | - | $35.19M(+562.6%) | -$157.30M(+3.0%) |
Jun 2018 | - | -$7.61M(+78.8%) | -$162.21M(+20.4%) |
Mar 2018 | - | -$35.90M(+75.9%) | -$203.90M(-24.5%) |
Dec 2017 | -$163.73M(-113.3%) | -$148.99M(-592.0%) | -$163.73M(-2698.5%) |
Sep 2017 | - | $30.28M(+161.4%) | $6.30M(+140.0%) |
Jun 2017 | - | -$49.29M(-1255.7%) | -$15.74M(-147.5%) |
Mar 2017 | - | $4.26M(-79.7%) | $33.12M(+143.1%) |
Dec 2016 | -$76.77M(-1403.8%) | $21.05M(+155.2%) | -$76.77M(+31.8%) |
Sep 2016 | - | $8.25M(+1995.6%) | -$112.57M(-12.0%) |
Jun 2016 | - | -$435.00K(+99.6%) | -$100.52M(-12.5%) |
Mar 2016 | - | -$105.62M(-615.8%) | -$89.31M(-1616.9%) |
Dec 2015 | $5.89M(+117.9%) | -$14.76M(-172.7%) | $5.89M(-82.7%) |
Sep 2015 | - | $20.29M(+88.4%) | $34.13M(+107.3%) |
Jun 2015 | - | $10.77M(+203.4%) | $16.46M(+9245.0%) |
Mar 2015 | - | -$10.42M(-177.3%) | -$180.00K(+99.5%) |
Dec 2014 | -$32.95M(+31.2%) | $13.48M(+413.0%) | -$32.95M(+25.8%) |
Sep 2014 | - | $2.63M(+144.8%) | -$44.42M(+6.2%) |
Jun 2014 | - | -$5.87M(+86.4%) | -$47.37M(-13.9%) |
Mar 2014 | - | -$43.19M(-2241.3%) | -$41.58M(+13.1%) |
Dec 2013 | -$47.87M | $2.02M(+720.6%) | -$47.87M(+5.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2013 | - | -$325.00K(-306.3%) | -$50.43M(-0.3%) |
Jun 2013 | - | -$80.00K(+99.8%) | -$50.27M(+1.3%) |
Mar 2013 | - | -$49.48M(-9066.5%) | -$50.91M(-3503.0%) |
Dec 2012 | -$1.41M(-70.5%) | -$539.80K(-222.3%) | -$1.41M(+1.2%) |
Sep 2012 | - | -$167.50K(+76.8%) | -$1.43M(-9.9%) |
Jun 2012 | - | -$721.50K(-4666.5%) | -$1.30M(-113.5%) |
Mar 2012 | - | $15.80K(+102.8%) | -$609.70K(+26.4%) |
Dec 2011 | -$828.50K(-28.2%) | -$557.00K(-1328.2%) | -$828.50K(-37.6%) |
Sep 2011 | - | -$39.00K(-32.2%) | -$602.20K(+3.5%) |
Jun 2011 | - | -$29.50K(+85.5%) | -$623.80K(+10.9%) |
Mar 2011 | - | -$203.00K(+38.6%) | -$700.40K(-8.4%) |
Dec 2010 | -$646.50K(+55.7%) | -$330.70K(-445.7%) | -$646.40K(+26.5%) |
Sep 2010 | - | -$60.60K(+42.9%) | -$879.10K(+9.3%) |
Jun 2010 | - | -$106.10K(+28.8%) | -$969.40K(+24.9%) |
Mar 2010 | - | -$149.00K(+73.6%) | -$1.29M(+11.6%) |
Dec 2009 | -$1.46M(-26.0%) | -$563.40K(-273.4%) | -$1.46M(-27.0%) |
Sep 2009 | - | -$150.90K(+64.7%) | -$1.15M(+19.8%) |
Jun 2009 | - | -$427.80K(-34.1%) | -$1.43M(-12.6%) |
Mar 2009 | - | -$319.00K(-26.4%) | -$1.27M(-9.8%) |
Dec 2008 | -$1.16M(+51.0%) | -$252.40K(+42.0%) | -$1.16M(+40.2%) |
Sep 2008 | - | -$435.40K(-63.1%) | -$1.94M(+0.1%) |
Jun 2008 | - | -$267.00K(-30.2%) | -$1.94M(+19.4%) |
Mar 2008 | - | -$205.00K(+80.2%) | -$2.41M(-1.9%) |
Dec 2007 | -$2.37M(-548.4%) | -$1.03M(-136.6%) | -$2.37M(-64.1%) |
Sep 2007 | - | -$436.70K(+40.5%) | -$1.44M(-24.2%) |
Jun 2007 | - | -$734.50K(-356.5%) | -$1.16M(-138.5%) |
Mar 2007 | - | -$160.90K(-47.2%) | -$486.80K(-33.4%) |
Dec 2006 | -$364.80K(-4.0%) | -$109.30K(+30.0%) | -$364.80K(-38.8%) |
Sep 2006 | - | -$156.20K(-158.6%) | -$262.90K(-29.3%) |
Jun 2006 | - | -$60.40K(-55.3%) | -$203.40K(+21.5%) |
Mar 2006 | - | -$38.90K(-425.7%) | -$259.10K(+26.2%) |
Dec 2005 | -$350.90K(-53.9%) | -$7400.00(+92.3%) | -$350.90K(+23.6%) |
Sep 2005 | - | -$96.70K(+16.7%) | -$459.00K(-18.9%) |
Jun 2005 | - | -$116.10K(+11.2%) | -$386.20K(-22.0%) |
Mar 2005 | - | -$130.70K(-13.2%) | -$316.60K(-38.9%) |
Dec 2004 | -$228.00K(>-9900.0%) | -$115.50K(-383.3%) | -$227.90K(-328.4%) |
Sep 2004 | - | -$23.90K(+48.6%) | -$53.20K(-21.2%) |
Jun 2004 | - | -$46.50K(-10.7%) | -$43.90K(-4.5%) |
Mar 2004 | - | -$42.00K(-170.9%) | -$42.00K(>-9900.0%) |
Dec 2003 | $0.00(0.0%) | $59.20K(+505.5%) | $0.00(+100.0%) |
Sep 2003 | - | -$14.60K(+67.3%) | -$34.20K(-74.5%) |
Jun 2003 | - | -$44.60K(>-9900.0%) | -$19.60K(>-9900.0%) |
Mar 2003 | - | $0.00(-100.0%) | $0.00(0.0%) |
Dec 2002 | $0.00(0.0%) | $25.00K(>+9900.0%) | $0.00(+100.0%) |
Sep 2002 | - | $0.00(+100.0%) | -$25.00K(0.0%) |
Jun 2002 | - | -$25.00K(>-9900.0%) | -$25.00K(>-9900.0%) |
Mar 2002 | - | $0.00 | $0.00 |
Dec 2001 | $0.00 | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual cash from investing year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly cash from investing year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM cash from investing year-on-year change?
What is Halozyme Therapeutics, Inc. annual cash from investing?
The current annual cash from investing of HALO is -$262.72M
What is the all-time high annual cash from investing for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual cash from investing is $78.35M
What is Halozyme Therapeutics, Inc. annual cash from investing year-on-year change?
Over the past year, HALO annual cash from investing has changed by -$165.81M (-171.10%)
What is Halozyme Therapeutics, Inc. quarterly cash from investing?
The current quarterly cash from investing of HALO is $84.79M
What is the all-time high quarterly cash from investing for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly cash from investing is $84.79M
What is Halozyme Therapeutics, Inc. quarterly cash from investing year-on-year change?
Over the past year, HALO quarterly cash from investing has changed by +$126.83M (+301.69%)
What is Halozyme Therapeutics, Inc. TTM cash from investing?
The current TTM cash from investing of HALO is -$143.64M
What is the all-time high TTM cash from investing for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM cash from investing is $128.08M
What is Halozyme Therapeutics, Inc. TTM cash from investing year-on-year change?
Over the past year, HALO TTM cash from investing has changed by +$72.82M (+33.64%)